drugset / Trial / NCT02193620

Study of PHN131 in Patients After Surgery

NCT02193620

Phase 2/3 Completed 106 enrolled PhytoHealth Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess the effectiveness, safety and pharmacokinetics of Oral Nalbuphine in the treatment of postoperative pain following hemorrhoidectomy.

Timeline

Start
2013-04-30
Primary completion
2014-09-21
Completion
2019-02-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Nalbuphine Small molecule 60 mg Oral
Background Diclofenac Other / unclassified Intramuscular

Indications

No indication recorded.